help button home button Am J Pathol International Conference on Pathology of Chest Diseases
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zwaka, T. P.
Right arrow Articles by Torzewski, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zwaka, T. P.
Right arrow Articles by Torzewski, J.
(American Journal of Pathology. 2002;161:449-457.)
© 2002 American Society for Investigative Pathology

Regular Articles

Complement and Dilated Cardiomyopathy

A Role of Sublytic Terminal Complement Complex-Induced Tumor Necrosis Factor-{alpha} Synthesis in Cardiac Myocytes

Thomas P. Zwaka*, Dimitar Manolov*, Cüneyt Özdemir*, Nikolaus Marx*, Ziya Kaya{dagger}, Matthias Kochs*, Martin Höher*, Vinzenz Hombach* and Jan Torzewski*

From the Department of Internal Medicine II–Cardiology,*University of Ulm, Ulm, Germany; and the Department of Molecular Microbiology and Immunology,{dagger}The Johns Hopkins Medical Institutions, Baltimore, Maryland

Dilated cardiomyopathy is a syndrome characterized by cardiac enlargement and impaired systolic function of the heart. Tumor necrosis factor (TNF)-{alpha}, a pleiotropic cytokine, seems to play a central role in the progression of dilated cardiomyopathy. Recent data suggest that ongoing inflammation in the myocardium may, in many cases, contribute to the development of disease. Chronic generation of autoantibodies to myocardial antigens or, in some cases, viral infection are pathobiologically involved. Although both antibodies and some viruses activate the complement system, the role of innate immunity in dilated cardiomyopathy has as yet not been investigated systematically. In this study we demonstrate by analysis of myocardial biopsies from 28 patients that C5b-9, the terminal membrane attack complex of complement, accumulates in human myocardium in dilated cardiomyopathy. C5b-9 significantly correlates with immunoglobulin deposition and myocardial expression of TNF-{alpha}. In vitro, C5b-9 attack on cardiac myocytes induces nuclear factor (NF)-{kappa}B activation as well as transcription, synthesis, and secretion of TNF-{alpha}. We conclude that chronic immunoglobulin-mediated complement activation in the myocardium may contribute in part to the progression of dilated cardiomyopathy via C5b-9-induced TNF-{alpha} expression in cardiac myocytes.




This article has been cited by other articles:


Home page
 J. Immunol.Home page
D. Fairweather, S. Frisancho-Kiss, D. B. Njoku, J. F. Nyland, Z. Kaya, S. A. Yusung, S. E. Davis, J. A. Frisancho, M. A. Barrett, and N. R. Rose
Complement Receptor 1 and 2 Deficiency Increases Coxsackievirus B3-Induced Myocarditis, Dilated Cardiomyopathy, and Heart Failure by Increasing Macrophages, IL-1beta, and Immune Complex Deposition in the Heart
J. Immunol., March 15, 2006; 176(6): 3516 - 3524.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. Berman, G. Girardi, and J. E. Salmon
TNF-{alpha} Is a Critical Effector and a Target for Therapy in Antiphospholipid Antibody-Induced Pregnancy Loss
J. Immunol., January 1, 2005; 174(1): 485 - 490.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
Y. Matsumoto, Y. Tsukada, A. Miyakoshi, H. Sakuma, and K. Kohyama
C Protein-Induced Myocarditis and Subsequent Dilated Cardiomyopathy: Rescue from Death and Prevention of Dilated Cardiomyopathy by Chemokine Receptor DNA Therapy
J. Immunol., September 1, 2004; 173(5): 3535 - 3541.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
A. Baba, T. Yoshikawa, Y. Fukuda, T. Sugiyama, M. Shimada, M. Akaishi, K. Tsuchimoto, S. Ogawa, and M. Fu
Autoantibodies against M2-muscarinic acetylcholine receptors: new upstream targets in atrial fibrillation in patients with dilated cardiomyopathy
Eur. Heart J., July 1, 2004; 25(13): 1108 - 1115.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
M. Afanasyeva and N. R. Rose
Cardiomyopathy Is Linked to Complement Activation
Am. J. Pathol., August 1, 2002; 161(2): 351 - 357.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the American Society for Investigative Pathology.